Articles on weight-loss medicines: how GLP-1 drugs and similar treatments work, who they are intended for, the side effects to expect and what happens when treatment stops. These are prescription medicines that need medical supervision.
Compounded tirzepatide is a pharmacy-made version of the prescription medicine tirzepatide that has not been reviewed or approved by the US Food and Drug…
Ozempic is prescribed off-label for weight loss because its active ingredient, semaglutide, is the same molecule sold as Wegovy for weight management, while Ozempic…
Wegovy (semaglutide) and Zepbound (tirzepatide) are both weekly injections approved for chronic weight management in adults with obesity, or overweight plus a weight-related condition.…
A GLP-1 receptor agonist is a medicine that imitates glucagon-like peptide-1, a hormone the gut releases after eating. By activating the same receptors, it…
GLP-1 medications are prescription medicines that mimic glucagon-like peptide-1, a gut hormone that boosts insulin release after meals, slows stomach emptying and reduces appetite.…
When you stop taking Ozempic, appetite usually returns within a few weeks as the medicine clears from the body, and in clinical trials most…
Compounded semaglutide is a version of the GLP-1 medicine mixed by a pharmacy or outsourcing facility rather than made by the licensed manufacturer. It…
A gastric sleeve typically removes more weight than Ozempic (semaglutide): roughly 25 to 30 percent of body weight after surgery versus about 15 percent…
Ozempic (semaglutide) and Mounjaro (tirzepatide) slow stomach emptying, so food can remain in the stomach after a standard preoperative fast, raising the risk of…
Ozempic is not approved for prediabetes; its US label covers type 2 diabetes. Semaglutide, the same molecule sold as Wegovy, is approved for weight…
On Ozempic (semaglutide), most dietitians suggest building each smaller meal around a lean protein, adding fiber-rich vegetables, fruit, beans or whole grains gradually, and…
Ozempic (semaglutide) is not approved for polycystic ovary syndrome; any use for PCOS is off-label. Small, short trials of GLP-1 medicines in women with…
Ozempic (semaglutide) does not appear to harm bone directly; randomized trials and pooled analyses of GLP-1 medicines show no clear rise in fractures. The…
On GLP-1 medicines such as semaglutide and tirzepatide, roughly 25 to 40 percent of the weight lost in trial body-composition substudies was lean mass,…
Ozempic constipation, nausea and sulfur burps share one root cause: the medicine slows how fast food leaves the stomach and moves through the gut.…
Hair loss on Ozempic or Mounjaro is usually telogen effluvium, a temporary shedding that begins two to four months after rapid weight loss or…
Drinking alcohol while taking Ozempic (semaglutide) is not prohibited by its prescribing information, but the combination can raise the risk of low blood sugar,…
Ozempic (semaglutide) carries a US boxed warning because it caused thyroid C-cell tumors in rats and mice; whether that applies to people is unknown.…
Choose which cookies you allow. Essential cookies are always on because the site cannot work without them.
